Showing results (11-20 of 103) with videos related to

Sort By:
Pageof 11
Lupus|April 9, 2020
Serum levels of soluble programmed cell death protein 1 and soluble programmed cell death protein ligand 2 are increased in systemic lupus erythematosus and associated with the disease activityShinya Hirahara, Yasuhiro Katsumata, Hidenaga Kawasumi, et al.
JMA Journal|December 16, 2020
Management of End-stage Renal Disease Associated with Systemic Rheumatic DiseasesSuguru Honda, Yasuhiro Katsumata, Kazunori Karasawa, et al.
Lupus|May 19, 2025
Validity and reliability of the Japanese version of LupusQoL: Assessment of disease-specific health-related quality of life in systemic lupus erythematosusSayuri Yamashita, Yasuhiro Katsumata, Sayumi Baba, et al.
Modern Rheumatology|May 30, 2025
Health-related quality of life and work productivity in Japanese patients with primarily stable ANCA-associated vasculitis: A multicenter cross-sectional studyShinya Hirahara, Yasuhiro Katsumata, Ken-Ei Sada, et al.
Arthritis and Rheumatism|June 10, 2003
Anti-c-Mpl (thrombopoietin receptor) autoantibody-induced amegakaryocytic thrombocytopenia in a patient with systemic sclerosisYasuhiro Katsumata, Takahiro Suzuki, Masataka Kuwana, et al.
Modern Rheumatology|December 15, 2021
Trends in actual medication use for child-onset systemic lupus erythematosus using the Japanese health insurance database 2009-18Takayuki Kishi, Ryoko Sakai, Yumi Tani, et al.
Modern Rheumatology|December 21, 2011
Semiquantitative measurement of aquaporin-4 antibodies as a possible surrogate marker of neuromyelitis optica spectrum disorders with systemic autoimmune diseasesYasuhiro Katsumata, Izumi Kawachi, Yasushi Kawaguchi, et al.
Modern Rheumatology|June 11, 2022
Comparisons between US norm-based two-component and Japanese norm-based three-component SF-36 summary scores in systemic lupus erythematosus patientsSayuri Yamashita, Yasuhiro Katsumata, Naoko Konda, et al.
Modern Rheumatology Case Reports|August 8, 2020
Tumour necrosis factor inhibitor-induced myositis in a patient with ulcerative colitisAkitsu Yoshida, Yasuhiro Katsumata, Shinya Hirahara, et al.
The Journal of Rheumatology|April 17, 2018
Association of Serum Soluble CD163 with Polymyositis and Dermatomyositis, Especially in Anti-MDA5 Antibody-positive CasesHidenaga Kawasumi, Yasuhiro Katsumata, Akira Nishino, et al.
Pageof 11